Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes.
about
Metabolomics: Bridging the Gap between Pharmaceutical Development and Population HealthMetabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus.Discovery and identification of potential biomarkers for alcohol-induced oxidative stress based on cellular metabolomics.Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review.Personalised Interventions-A Precision Approach for the Next Generation of Dietary Intervention Studies.
P2860
Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Metabolomic biomarkers for per ...... treatment in type 2 diabetes.
@ast
Metabolomic biomarkers for per ...... treatment in type 2 diabetes.
@en
type
label
Metabolomic biomarkers for per ...... treatment in type 2 diabetes.
@ast
Metabolomic biomarkers for per ...... treatment in type 2 diabetes.
@en
prefLabel
Metabolomic biomarkers for per ...... treatment in type 2 diabetes.
@ast
Metabolomic biomarkers for per ...... treatment in type 2 diabetes.
@en
P2093
P2860
P1433
P1476
Metabolomic biomarkers for per ...... treatment in type 2 diabetes.
@en
P2093
Ben van Ommen
Carina M Rubingh
Guy E H M Rutten
Henk den Ouden
Ilse K Geerars-van Vonderen
Joline W J Beulens
Linette Pellis
Marjan J van Erk
P2860
P2888
P356
10.1007/S11306-015-0930-4
P577
2016-01-06T00:00:00Z